Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert F Smit

Showing results (31-40 of 367) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|January 24, 2024
Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLCAnne-Marie C Dingemans, Egbert F Smit, Lizza E L Hendriks
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Pituitary gland: do anticancer drugs sit in the Turkish saddle?Astrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
Cell Cycle (Georgetown, Tex.)|October 4, 2012
Scheduling of anticancer drugs: timing may be everythingAstrid A M Van der Veldt, Adriaan A Lammertsma, Egbert F Smit
Clinical Chemistry and Laboratory Medicine|March 18, 2015
Real-world costs of laboratory tests for non-small cell lung cancerNaomi van der Linden, Egbert F Smit, Carin A Uyl-de Groot
Nederlands Tijdschrift Voor Geneeskunde|March 23, 2011
[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible]Erik Thunnissen, Egbert F Smit, Petra M Nederlof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Stereotactic radiotherapy for centrally located early-stage lung tumorsSuresh Senan, Niels J A Haasbeek, Egbert F Smit, et al.
Thyroid : Official Journal of the American Thyroid Association|April 4, 2013
Reduction in thyroid perfusion after bevacizumab treatmentAstrid A M van der Veldt, Adriaan A Lammertsma, Egbert F Smit
Expert Review of Anticancer Therapy|April 9, 2013
Cancer therapy: could a novel test predict the amount of drug that reaches its target?Astrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
Frontiers in Oncology|August 30, 2013
Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxelAstrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
International Journal of Radiation Oncology, Biology, Physics|March 18, 2009
Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancerJoline S W Lind, Frank J Lagerwaard, Egbert F Smit, et al.
Pageof 37

Showing results (31-40 of 367) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|January 24, 2024
Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLCAnne-Marie C Dingemans, Egbert F Smit, Lizza E L Hendriks
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Pituitary gland: do anticancer drugs sit in the Turkish saddle?Astrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
Cell Cycle (Georgetown, Tex.)|October 4, 2012
Scheduling of anticancer drugs: timing may be everythingAstrid A M Van der Veldt, Adriaan A Lammertsma, Egbert F Smit
Clinical Chemistry and Laboratory Medicine|March 18, 2015
Real-world costs of laboratory tests for non-small cell lung cancerNaomi van der Linden, Egbert F Smit, Carin A Uyl-de Groot
Nederlands Tijdschrift Voor Geneeskunde|March 23, 2011
[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible]Erik Thunnissen, Egbert F Smit, Petra M Nederlof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Stereotactic radiotherapy for centrally located early-stage lung tumorsSuresh Senan, Niels J A Haasbeek, Egbert F Smit, et al.
Thyroid : Official Journal of the American Thyroid Association|April 4, 2013
Reduction in thyroid perfusion after bevacizumab treatmentAstrid A M van der Veldt, Adriaan A Lammertsma, Egbert F Smit
Expert Review of Anticancer Therapy|April 9, 2013
Cancer therapy: could a novel test predict the amount of drug that reaches its target?Astrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
Frontiers in Oncology|August 30, 2013
Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxelAstrid A M van der Veldt, Egbert F Smit, Adriaan A Lammertsma
International Journal of Radiation Oncology, Biology, Physics|March 18, 2009
Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancerJoline S W Lind, Frank J Lagerwaard, Egbert F Smit, et al.
Pageof 37